Apex Biotechnology Corp. (TPE:1733)
Taiwan · Delayed Price · Currency is TWD 28.95
-0.05 (-0.17%)
Aug 13, 2025, 1:30 PM CST
Apex Biotechnology Revenue
Apex Biotechnology had revenue of 509.95M TWD in the quarter ending June 30, 2025, with 16.43% growth. This brings the company's revenue in the last twelve months to 2.03B, up 18.75% year-over-year. In the year 2024, Apex Biotechnology had annual revenue of 1.85B with 10.48% growth.
Revenue (ttm)
2.03B
Revenue Growth
+18.75%
P/S Ratio
1.43
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.85B | 175.67M | 10.48% |
| Dec 31, 2023 | 1.68B | -567.64M | -25.29% |
| Dec 31, 2022 | 2.24B | 112.52M | 5.28% |
| Dec 31, 2021 | 2.13B | 126.32M | 6.30% |
| Dec 31, 2020 | 2.01B | -193.53M | -8.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 44.83M |
| PharmaEssentia | 11.34B |
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| Oneness Biotech | 112.57M |
| Polaris Group | 87.67M |
| Center Laboratories | 1.63B |
| Lumosa Therapeutics | 37.25M |